metoprolol has been researched along with Cardiomyopathies in 34 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To focus on evaluating the clinical influence of metoprolol on sepsis-induced cardiomyopathy (SICM)." | 8.31 | The influence of metoprolol in patients with sepsis-induced cardiomyopathy: A retrospective study. ( Chen, Y; Li, L; Lu, J; Ning, W; Zhu, J, 2023) |
| "Relative effectiveness of carvedilol and metoprolol succinate has never been compared in patients with heart failure (HF)." | 7.78 | Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis. ( Aggarwal, V; Shore, S; Zolty, R, 2012) |
| " Secondary: changes of a) LV-FS from baseline, b) blood pressure, c), heart rate and autonomic function in ECG and Holter-ECG, e) cardiac biomarkers and neurohumeral serum parameters, f) quality of life, and g) adverse events." | 6.90 | Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial. ( Dittrich, S; Ebinger, F; Graf, E; Heilmann, A; Khalil, M; Kirschner, J; Korenke, C; Lange, M; Motz, R; Müller-Felber, W; Neudorf, U; Pattathu, J; Pozza, RD; Schara, U; Schröder, R; Stiller, B; Trollmann, R; von Au, K; von der Hagen, M; Weiss, K; Wiechmann, N; Wilichowski, E, 2019) |
| "To focus on evaluating the clinical influence of metoprolol on sepsis-induced cardiomyopathy (SICM)." | 4.31 | The influence of metoprolol in patients with sepsis-induced cardiomyopathy: A retrospective study. ( Chen, Y; Li, L; Lu, J; Ning, W; Zhu, J, 2023) |
| "Background Whether chronic obstructive sleep apnea ( OSA ) could promote epicardial adipose tissue ( EAT ) secretion of profibrotic adipokines, and thereby contribute to atrial fibrosis, and the potential therapeutic effects of metoprolol remain unknown." | 3.91 | Metoprolol Inhibits Profibrotic Remodeling of Epicardial Adipose Tissue in a Canine Model of Chronic Obstructive Sleep Apnea. ( Dai, H; Gong, Y; Han, Y; Li, T; Li, Y; Sheng, L; Sun, L; Xu, J; Yin, S; Yuan, Y; Zhang, Y, 2019) |
| "Relative effectiveness of carvedilol and metoprolol succinate has never been compared in patients with heart failure (HF)." | 3.78 | Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis. ( Aggarwal, V; Shore, S; Zolty, R, 2012) |
| "The use of beta-blocking drugs for dilated cardiomyopathy (DCM), however, is currently investigational." | 3.76 | Treatment of cardiac myopathies with beta blockers. What do we know, where do we go from here? ( Anderson, JL, 1988) |
| " Secondary: changes of a) LV-FS from baseline, b) blood pressure, c), heart rate and autonomic function in ECG and Holter-ECG, e) cardiac biomarkers and neurohumeral serum parameters, f) quality of life, and g) adverse events." | 2.90 | Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial. ( Dittrich, S; Ebinger, F; Graf, E; Heilmann, A; Khalil, M; Kirschner, J; Korenke, C; Lange, M; Motz, R; Müller-Felber, W; Neudorf, U; Pattathu, J; Pozza, RD; Schara, U; Schröder, R; Stiller, B; Trollmann, R; von Au, K; von der Hagen, M; Weiss, K; Wiechmann, N; Wilichowski, E, 2019) |
| "Most patients with Duchenne muscular dystrophy (DMD) will develop cardiomyopathy; however, the evidence for prophylactic treatment of children with cardiac medications is limited." | 1.42 | Absence of Cardiac Benefit with Early Combination ACE Inhibitor and Beta Blocker Treatment in mdx Mice. ( Blain, A; Blamire, AM; Greally, E; Laval, SH; MacGowan, GA; Straub, VW, 2015) |
| "With metoprolol there was an increase in right ventricular end-diastolic and end-systolic volumes." | 1.39 | Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy. ( Blain, A; Blamire, A; Greally, E; Laval, S; MacGowan, GA; Straub, V, 2013) |
| "Hypertension is associated with left ventricular hypertrophy (LVH) and diastolic dysfunction." | 1.35 | Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits. ( Bousquet, PP; Monassier, LJ; Signolet, IL, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.82) | 18.7374 |
| 1990's | 4 (11.76) | 18.2507 |
| 2000's | 9 (26.47) | 29.6817 |
| 2010's | 12 (35.29) | 24.3611 |
| 2020's | 6 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C | 1 |
| Tian, J | 1 |
| He, Z | 1 |
| Xiong, W | 1 |
| He, Y | 1 |
| Liu, S | 1 |
| Ning, W | 1 |
| Chen, Y | 1 |
| Lu, J | 1 |
| Zhu, J | 1 |
| Li, L | 1 |
| Rajendram, R | 1 |
| AlDhahri, F | 1 |
| Mahmood, N | 1 |
| Kharal, M | 1 |
| Juusela, A | 1 |
| Nazir, M | 1 |
| Gimovsky, M | 1 |
| Eijgenraam, TR | 1 |
| Boukens, BJ | 1 |
| Boogerd, CJ | 1 |
| Schouten, EM | 1 |
| van de Kolk, CWA | 1 |
| Stege, NM | 1 |
| Te Rijdt, WP | 1 |
| Hoorntje, ET | 1 |
| van der Zwaag, PA | 1 |
| van Rooij, E | 1 |
| van Tintelen, JP | 1 |
| van den Berg, MP | 1 |
| van der Meer, P | 1 |
| van der Velden, J | 1 |
| Silljé, HHW | 1 |
| de Boer, RA | 1 |
| Padkins, MR | 1 |
| Bell, MR | 1 |
| Sönmez, BM | 1 |
| İşcanlı, MD | 1 |
| Durdu, T | 1 |
| Kala, İ | 1 |
| Tarhan, N | 1 |
| Uysal, P | 1 |
| Silvestre, OM | 1 |
| Farias, AQ | 1 |
| Ramos, DS | 1 |
| Furtado, MS | 1 |
| Rodrigues, AC | 1 |
| Ximenes, RO | 1 |
| de Campos Mazo, DF | 1 |
| Yoshimura Zitelli, PM | 1 |
| Diniz, MA | 1 |
| Andrade, JL | 1 |
| Strunz, C | 1 |
| Friedmann, AA | 1 |
| Lee, SS | 1 |
| Carrilho, FJ | 1 |
| D'Albuquerque, LAC | 1 |
| Bacal, F | 1 |
| Erolu, E | 1 |
| Akalın, F | 1 |
| Saylan Çevik, B | 1 |
| Yücelten, D | 1 |
| Chamorro-Pareja, N | 1 |
| Marin-Acevedo, JA | 1 |
| Chirilă, RM | 1 |
| Dai, H | 1 |
| Yuan, Y | 1 |
| Yin, S | 1 |
| Zhang, Y | 1 |
| Han, Y | 1 |
| Sun, L | 1 |
| Li, T | 1 |
| Xu, J | 1 |
| Sheng, L | 1 |
| Gong, Y | 1 |
| Li, Y | 1 |
| Dittrich, S | 1 |
| Graf, E | 1 |
| Trollmann, R | 1 |
| Neudorf, U | 1 |
| Schara, U | 1 |
| Heilmann, A | 1 |
| von der Hagen, M | 1 |
| Stiller, B | 1 |
| Kirschner, J | 1 |
| Pozza, RD | 1 |
| Müller-Felber, W | 1 |
| Weiss, K | 1 |
| von Au, K | 1 |
| Khalil, M | 1 |
| Motz, R | 1 |
| Korenke, C | 1 |
| Lange, M | 1 |
| Wilichowski, E | 1 |
| Pattathu, J | 1 |
| Ebinger, F | 1 |
| Wiechmann, N | 1 |
| Schröder, R | 1 |
| Blain, A | 2 |
| Greally, E | 2 |
| Laval, S | 1 |
| Blamire, A | 1 |
| Straub, V | 1 |
| MacGowan, GA | 2 |
| Laval, SH | 1 |
| Blamire, AM | 1 |
| Straub, VW | 1 |
| Ge, H | 1 |
| Li, X | 1 |
| Liu, H | 1 |
| Jiang, H | 1 |
| Nazeri, A | 1 |
| Elayda, MA | 1 |
| Segura, AM | 1 |
| Stainback, RF | 1 |
| Nathan, J | 1 |
| Lee, VV | 1 |
| Bove, C | 1 |
| Sampaio, L | 1 |
| Grace, B | 1 |
| Massumi, A | 1 |
| Razavi, M | 1 |
| Schmittinger, CA | 1 |
| Dünser, MW | 1 |
| Haller, M | 1 |
| Ulmer, H | 1 |
| Luckner, G | 1 |
| Torgersen, C | 1 |
| Jochberger, S | 1 |
| Hasibeder, WR | 1 |
| Seeland, U | 1 |
| Schäffer, A | 1 |
| Selejan, S | 1 |
| Hohl, M | 1 |
| Reil, JC | 1 |
| Müller, P | 1 |
| Rosenkranz, S | 1 |
| Böhm, M | 1 |
| He, L | 1 |
| Xiao, J | 1 |
| Fu, H | 1 |
| Du, G | 1 |
| Xiao, X | 1 |
| Zhang, C | 1 |
| Gu, Y | 1 |
| Ma, Y | 1 |
| Shore, S | 1 |
| Aggarwal, V | 1 |
| Zolty, R | 1 |
| Sibal, L | 1 |
| Jovanovic, A | 1 |
| Agarwal, SC | 1 |
| Peaston, RT | 1 |
| James, RA | 1 |
| Lennard, TW | 1 |
| Bliss, R | 1 |
| Batchelor, A | 1 |
| Perros, P | 1 |
| Simões, MV | 1 |
| Marin-Neto, JA | 1 |
| Romano, MM | 1 |
| O'Connell, JL | 1 |
| de Santi, GL | 1 |
| Maciel, BC | 1 |
| Signolet, IL | 1 |
| Bousquet, PP | 1 |
| Monassier, LJ | 1 |
| Liu, J | 1 |
| Mao, W | 1 |
| Iwai, C | 1 |
| Fukuoka, S | 1 |
| Vulapalli, R | 1 |
| Huang, H | 1 |
| Wang, T | 1 |
| Sharma, VK | 1 |
| Sheu, SS | 1 |
| Fu, M | 1 |
| Liang, CS | 1 |
| Okamoto, M | 1 |
| Hashimoto, M | 1 |
| Sueda, T | 1 |
| Munemori, M | 1 |
| Yamada, T | 1 |
| McMullan, MR | 1 |
| Moore, CK | 1 |
| O'Connell, JB | 1 |
| Andersson, B | 1 |
| Lomsky, M | 1 |
| Waagstein, F | 1 |
| Witte, K | 1 |
| Kinzler, N | 1 |
| Schnecko, A | 1 |
| Olbrich, HG | 1 |
| Lemmer, B | 1 |
| Noori, A | 1 |
| Lindenfeld, J | 1 |
| Wolfel, E | 1 |
| Ferguson, D | 1 |
| Bristow, MR | 1 |
| Lowes, BD | 1 |
| Beanlands, RS | 1 |
| Nahmias, C | 1 |
| Gordon, E | 1 |
| Coates, G | 1 |
| deKemp, R | 1 |
| Firnau, G | 1 |
| Fallen, E | 1 |
| Bennett, SK | 1 |
| Smith, MF | 1 |
| Gottlieb, SS | 1 |
| Fisher, ML | 1 |
| Bacharach, SL | 1 |
| Dilsizian, V | 1 |
| Kolin, A | 2 |
| Brezina, A | 2 |
| Lewis, AJ | 2 |
| Norris, JW | 2 |
| Anderson, JL | 1 |
| Kellen, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension[NCT05593055] | Phase 4 | 75 participants (Anticipated) | Interventional | 2023-08-25 | Recruiting | ||
| Effects of Long Term Adaptive Servo Ventilation Therapy on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea. The AMEND Sub-study[NCT02116140] | 60 participants (Anticipated) | Interventional | 2012-07-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for metoprolol and Cardiomyopathies
| Article | Year |
|---|---|
33-Year-Old Woman With Postpartum Acute Shortness of Breath.
Topics: Adrenergic beta-1 Receptor Antagonists; Cardiomyopathies; Cesarean Section; Dyspnea; Female; Humans; | 2020 |
Cardiac sarcoidosis: Case presentation and Review of the literature.
Topics: Cardiomyopathies; Cardiovascular Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressiv | 2019 |
Treatment of cardiac myopathies with beta blockers. What do we know, where do we go from here?
Topics: Adrenergic beta-Antagonists; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic | 1988 |
4 trials available for metoprolol and Cardiomyopathies
28 other studies available for metoprolol and Cardiomyopathies
| Article | Year |
|---|---|
Identified Three Interferon Induced Proteins as Novel Biomarkers of Human Ischemic Cardiomyopathy.
Topics: Animals; Apoptosis Regulatory Proteins; Biomarkers; Cardiomyopathies; Disease Models, Animal; Gene R | 2021 |
The influence of metoprolol in patients with sepsis-induced cardiomyopathy: A retrospective study.
Topics: Cardiomyopathies; Humans; Metoprolol; Norepinephrine; Retrospective Studies; Sepsis | 2023 |
The use of ivabradine in a patient with inappropriate sinus tachycardia and cardiomyopathy due to limb girdle muscular dystrophy type 2I.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Cardiovascular Agents; Diagnosis, Differential; Female; Hu | 2020 |
Two cases of coronavirus 2019-related cardiomyopathy in pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Blood Gas Analysi | 2020 |
The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy.
Topics: Animals; Calcium-Binding Proteins; Cardiomyopathies; Eplerenone; Heart Failure; Metoprolol; Mice; Mu | 2020 |
What's going wrong with this postpartum woman?
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Anticoagulants; Cardiomyopathies; Cardiovascular Agen | 2018 |
Arrhythmogenic right ventricular dysplasia, cutaneous manifestations and desmoplakin mutation: Carvajal syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arrhythmogenic Rig | 2018 |
Metoprolol Inhibits Profibrotic Remodeling of Epicardial Adipose Tissue in a Canine Model of Chronic Obstructive Sleep Apnea.
Topics: Adipokines; Adipose Tissue; Animals; Cardiomyopathies; Chronic Disease; Disease Models, Animal; Dogs | 2019 |
Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Calcium; Cardiomyopathies; Ion Transport; Male; M | 2013 |
Absence of Cardiac Benefit with Early Combination ACE Inhibitor and Beta Blocker Treatment in mdx Mice.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Captopril; | 2015 |
Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Child; Child, Preschool; China; Drug Therapy, | 2017 |
Comparative Efficacy of Nebivolol and Metoprolol to Prevent Tachycardia-Induced Cardiomyopathy in a Porcine Model.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Cardiac Pacing, Artificial; Cardiomyopathies; Disea | 2016 |
Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression.
Topics: Aged; Aged, 80 and over; Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Male; Metoprol | 2008 |
Effects of AT1- and beta-adrenergic receptor antagonists on TGF-beta1-induced fibrosis in transgenic mice.
Topics: Animals; Benzimidazoles; Benzoates; Cardiomyopathies; Collagen; Metoprolol; Mice; Mice, Transgenic; | 2009 |
Effect of oxidative stress on ventricular arrhythmia in rabbits with adriamycin-induced cardiomyopathy.
Topics: Animals; Anti-Arrhythmia Agents; Antibiotics, Antineoplastic; Carbazoles; Cardiomyopathies; Carvedil | 2012 |
Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathies; Carvedilol; Cohort Studies; Delayed-Actio | 2012 |
Phaeochromocytomas presenting as acute crises after beta blockade therapy.
Topics: Acute Disease; Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic beta-Antagonists; Adult; Cardiomyo | 2006 |
Transient left ventricular dysfunction due to stress-induced cardiomyopathy.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; | 2007 |
Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cardiomyopathies; Dia | 2008 |
Adoptive passive transfer of rabbit beta1-adrenoceptor peptide immune cardiomyopathy into the Rag2-/- mouse: participation of the ER stress.
Topics: Adoptive Transfer; Animals; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomyo | 2008 |
Polymorphic ventricular tachycardia with cardiac sarcoidosis: treatment with low-dose metoprolol and cibenzoline.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Drug Therapy, Combination; Electrocardiography; Fem | 1994 |
Diagnosis and management of peripartum cardiomyopathy.
Topics: Adult; Algorithms; Captopril; Cardiomyopathies; Diagnosis, Differential; Digoxin; Drug Administratio | 1993 |
The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. A study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Cardiomyopathies; Diastole; Dose-Response Relat | 1993 |
Effects of beta-adrenoceptor blockade on beta-adrenergic signal transduction in cardiomyopathic hamster (BIO 8262) hearts.
Topics: 5'-Nucleotidase; Adenylyl Cyclases; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Recept | 1997 |
Beta-blockade in adriamycin-induced cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antineoplastic Agents; Carbazoles; Cardiomyopathies; Cardi | 2000 |
Effect of metoprolol on absolute myocardial blood flow in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiography; Cardiac Output; Cardiomyopathies; Chi-Square | 2002 |
Quantitative evaluation of myocardial injury induced by acute cerebral ischaemia and its prevention by beta 1-adrenergic blockade. An ultrastructural morphometry study.
Topics: Acute Disease; Animals; Brain Ischemia; Cardiomyopathies; Gerbillinae; Lipid Metabolism; Male; Metop | 1989 |
Reversible myocardial damage in gerbil brain ischaemia and its prevention by beta-adrenergic blockade.
Topics: Animals; Brain; Brain Ischemia; Cardiomyopathies; Carotid Arteries; Creatine Kinase; Gerbillinae; Li | 1988 |